Chiesi recalls

3 federal recalls on file. We read every CPSC, FDA, USDA and NHTSA notice for Chiesi and put it in plain English.

Recent recalls

  • Chiesi Revcovi injection recalled for stability failure

    Chiesi USA, Inc. is recalling Revcovi (elapegademase-lvlr) Injection due to out-of-specification stability results in the protein concentration profile. The affected lot was distributed to Missouri and Tennessee. No injuries have been reported.

    ModerateFDASep 9, 2026

  • Chiesi CLEVIPREX injection recalled for sterility concerns

    Chiesi USA is recalling specific lots of CLEVIPREX (clevidipine) injectable emulsion because the manufacturer cannot guarantee the vials are sterile. This affects vials distributed nationwide with lot numbers 1239521 and 1237454, expiring in October 2027. No injuries have been reported.

    ModerateFDAJul 22, 2026

  • Stop using recalled CUROSURF lung surfactant

    Chiesi USA is recalling specific lots of CUROSURF, a medication given to premature infants to help them breathe. The company cannot confirm that all vials are sterile, which means they may be contaminated. No infections have been reported so far.

    ModerateFDAApr 1, 2026

Explore other recall topics